ISRAEL ROBERT J
Insider CIK 1250274 · PGNX Senior VP Medical Affairs
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2015-06-11 | 2015-06-15 | 2,000 | $6.83 | $13.7K | 4,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2015-06-11 | 2015-06-15 | 2,000 | $6.83 | $13.7K | 35,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2015-06-11 | 2015-06-15 | 2,000 | $5.33 | $10.7K | 37,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2015-03-13 | 2015-03-16 | 3,000 | $7.00 | $21.0K | 15,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2015-03-13 | 2015-03-16 | 3,000 | $5.35 | $16.0K | 38,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2015-03-13 | 2015-03-16 | 3,000 | $7.00 | $21.0K | 35,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2015-03-11 | 2015-03-13 | 2,000 | $6.83 | $13.7K | 6,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2015-03-11 | 2015-03-13 | 2,000 | $6.83 | $13.7K | 35,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2015-03-11 | 2015-03-13 | 2,000 | $5.33 | $10.7K | 37,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2015-03-03 | 2015-03-04 | 5,000 | $6.49 | $32.5K | 61,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2015-03-03 | 2015-03-04 | 5,000 | $6.49 | $32.5K | 35,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2015-03-03 | 2015-03-04 | 5,000 | $4.70 | $23.5K | 40,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2015-03-02 | 2015-03-04 | 66,000 | $6.65 | $438.9K | 66,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2015-01-12 | 2015-01-13 | 2,000 | $7.06 | $14.1K | 8,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2015-01-12 | 2015-01-13 | 2,000 | $7.06 | $14.1K | 35,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2015-01-12 | 2015-01-13 | 2,000 | $5.33 | $10.7K | 37,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2014-12-11 | 2014-12-12 | 3,000 | $7.07 | $21.2K | 18,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2014-12-11 | 2014-12-12 | 3,000 | $5.35 | $16.0K | 38,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2014-12-11 | 2014-12-12 | 3,000 | $7.07 | $21.2K | 35,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2014-11-21 | 2014-11-21 | 9,000 | $7.00 | $63.0K | 21,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2014-11-21 | 2014-11-21 | 9,000 | $5.35 | $48.1K | 44,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2014-11-21 | 2014-11-21 | 9,000 | $7.00 | $63.0K | 35,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2014-11-13 | 2014-11-14 | 10,000 | $6.83 | $68.3K | 10,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2014-11-13 | 2014-11-14 | 10,000 | $6.83 | $68.3K | 35,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2014-11-13 | 2014-11-14 | 10,000 | $5.33 | $53.3K | 45,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2014-11-11 | 2014-11-12 | 5,000 | $6.53 | $32.6K | 55,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2014-11-11 | 2014-11-12 | 5,000 | $5.03 | $25.1K | 40,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2014-11-11 | 2014-11-12 | 5,000 | $6.53 | $32.6K | 35,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2014-03-03 | 2014-03-04 | 66,000 | $4.70 | $310.2K | 66,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2013-07-18 | 2013-07-22 | 5,000 | $6.33 | $31.6K | 20,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2013-07-18 | 2013-07-22 | 5,000 | $6.33 | $31.6K | 35,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2013-07-18 | 2013-07-22 | 5,000 | $5.33 | $26.6K | 40,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2013-04-04 | 2013-04-08 | 60,000 | $5.03 | $301.8K | 60,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2012-07-02 | 2012-07-03 | 1,000 | $9.79 | $9.8K | 25,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2012-07-02 | 2012-07-03 | 1,000 | $5.33 | $5.3K | 36,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2012-07-02 | 2012-07-03 | 1,000 | $9.79 | $9.8K | 35,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer | 2012-06-20 | 2012-06-22 | 3,333 | $8.58 | $28.6K | 35,050 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2012-06-01 | 2012-06-04 | 1,000 | $8.51 | $8.5K | 26,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2012-06-01 | 2012-06-04 | 1,000 | $5.33 | $5.3K | 39,383 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2012-06-01 | 2012-06-04 | 1,000 | $8.51 | $8.5K | 38,383 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2012-05-01 | 2012-05-03 | 1,000 | $10.93 | $10.9K | 27,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2012-05-01 | 2012-05-03 | 1,000 | $10.93 | $10.9K | 38,383 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2012-05-01 | 2012-05-03 | 1,000 | $5.33 | $5.3K | 39,383 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2012-04-02 | 2012-04-03 | 1,000 | $9.85 | $9.8K | 28,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2012-04-02 | 2012-04-03 | 1,000 | $9.85 | $9.8K | 38,383 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2012-04-02 | 2012-04-03 | 1,000 | $5.33 | $5.3K | 39,383 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2012-03-01 | 2012-03-02 | 1,000 | $9.82 | $9.8K | 29,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2012-03-01 | 2012-03-05 | 50,000 | $9.81 | $490.5K | 50,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2012-03-01 | 2012-03-02 | 1,000 | $5.33 | $5.3K | 39,383 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2012-03-01 | 2012-03-02 | 1,000 | $9.82 | $9.8K | 38,383 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2012-02-01 | 2012-02-02 | 1,000 | $9.48 | $9.5K | 30,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2012-02-01 | 2012-02-02 | 1,000 | $5.33 | $5.3K | 39,383 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2012-02-01 | 2012-02-02 | 1,000 | $9.48 | $9.5K | 38,383 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2012-01-03 | 2012-01-04 | 1,000 | $8.78 | $8.8K | 31,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2012-01-03 | 2012-01-04 | 1,000 | $5.33 | $5.3K | 39,383 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2012-01-03 | 2012-01-04 | 1,000 | $8.78 | $8.8K | 38,383 | SEC↗ |